Tumor Mutational Burden and COVID-19: A Pathologist’s Perspective

Episode
40
Soundcloud
Share

The latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.

Guest
Lynette Sholl
Lynette Sholl

MD

Associate Professor of Pathology and Associate Pathologist
Harvard Medical School
Brigham and Women's Hospital

Other Podcast

LALCA 2023 Highlights
Episode
144
Seminal Trials: iPass Study for EGFR NSCLC
Episode
142
Lung Cancer in Brazil
Episode
141